손지영 Ji-Young Sohn Email & Phone Number

Seoul, South Korea

I am delighted to join Moderna during an exciting period of growth for the company!In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA, to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years.

Korea

An exciting journey with CSL Behring as the first GM and a founder of Korea affiliate.CSL Behring is a global biotechnology leader, driven by the promise to save and improve lives. It offers the broadest range of quality plasma-derived and recombinant therapies in the industry. It’s ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned a reputation for always putting patients first. I am proud of being the instrumental members of CSL Behring’s growth, creating and developing Korea affiliate, driven by promise.

Korea, Switzerland, Singapore

2010-2014 Oncology Business Unit Head, Director and Country Leadership Team, Roche Korea- Responsible for P&L management. Drove unprecedented records of double-digit growths for 3 consecutive years (oncology portfolio, 130 mil CHF in revenue). Led 60 people, turning around the organization culture via strong people development and employee engagement. 2014-2017 International Portfolio Leader (Director), Roche HQ, Switzerland- Responsible for the Global Strategy of established products portfolio (Oncology and HIV) as the leader of global cross-functional Team (business, medical, development, regulatory, safety, manufacturing, supply)2017-2018 Project Management Office, Roche APAC, Singapore

Korea

All-round player and a professional marketing and business leader in Primary Cara, and Rare Diseases area. Feb 2009 - Oct 2010 : Specialty Business Unit Head/Director- P&L management. Led up to 40 people. Drove growths of 9 brands in rare disease (hospital critical care, schizophrenia, hemophilia, COPD, growth-hormone, and glaucoma/ophthalmology)Jun 2006 - Jan 2009 Marketing Manager / Associate DirectorP&L responsibility for 7 strategic products including 2 new launches in Primary Care business. Drove strong growth to 125 mil USD sales in neurology, rheumatology, orthopedics, and urology area. Feb 1999 - Jun 2006 Strategic Planning, Product Management, Disease Management, Market analytics Manager/Team Leader

Mba

Bachelor Of Pharmacy - Bpharm